These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26844764)

  • 1. Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF.
    Grodin JL; Lala A; Stevens SR; DeVore AD; Cooper LB; AbouEzzeddine OF; Mentz RJ; Groarke JD; Joyce E; Rosenthal JL; Vader JM; Tang WH
    J Card Fail; 2016 Nov; 22(11):884-890. PubMed ID: 26844764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Bicarbonate in Acute Heart Failure: Relationship to Treatment Strategies and Clinical Outcomes.
    Cooper LB; Mentz RJ; Gallup D; Lala A; DeVore AD; Vader JM; AbouEzzeddine OF; Bart BA; Anstrom KJ; Hernandez AF; Felker GM
    J Card Fail; 2016 Sep; 22(9):738-42. PubMed ID: 26777758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF).
    Grodin JL; Sun JL; Anstrom KJ; Chen HH; Starling RC; Testani JM; Tang WH
    Am J Cardiol; 2017 Jan; 119(1):78-83. PubMed ID: 27816115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.
    Brisco MA; Zile MR; Hanberg JS; Wilson FP; Parikh CR; Coca SG; Tang WH; Testani JM
    J Card Fail; 2016 Oct; 22(10):753-60. PubMed ID: 27374839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction.
    O'Connor CM; Mentz RJ; Cotter G; Metra M; Cleland JG; Davison BA; Givertz MM; Mansoor GA; Ponikowski P; Teerlink JR; Voors AA; Fiuzat M; Wojdyla D; Chiswell K; Massie BM
    Eur J Heart Fail; 2012 Jun; 14(6):605-12. PubMed ID: 22535795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF).
    Grodin JL; Gallup D; Anstrom KJ; Felker GM; Chen HH; Tang WHW
    Am J Cardiol; 2017 Jun; 119(12):2003-2009. PubMed ID: 28433216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
    Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
    Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM;
    Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).
    Lala A; McNulty SE; Mentz RJ; Dunlay SM; Vader JM; AbouEzzeddine OF; DeVore AD; Khazanie P; Redfield MM; Goldsmith SR; Bart BA; Anstrom KJ; Felker GM; Hernandez AF; Stevenson LW
    Circ Heart Fail; 2015 Jul; 8(4):741-8. PubMed ID: 26041600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance Between Hemoconcentration and Clinical Assessment of Decongestion in Acute Heart Failure.
    Darawsha W; Chirmicci S; Solomonica A; Wattad M; Kaplan M; Makhoul BF; Abassi ZA; Azzam ZS; Aronson D
    J Card Fail; 2016 Sep; 22(9):680-8. PubMed ID: 27079674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
    Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
    Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials.
    Vader JM; LaRue SJ; Stevens SR; Mentz RJ; DeVore AD; Lala A; Groarke JD; AbouEzzeddine OF; Dunlay SM; Grodin JL; Dávila-Román VG; de las Fuentes L
    J Card Fail; 2016 Nov; 22(11):875-883. PubMed ID: 27133201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline albumin is associated with worsening renal function in patients with acute decompensated heart failure receiving continuous infusion loop diuretics.
    Clarke MM; Dorsch MP; Kim S; Aaronson KD; Koelling TM; Bleske BE
    Pharmacotherapy; 2013 Jun; 33(6):583-8. PubMed ID: 23553379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function.
    Breidthardt T; Weidmann ZM; Twerenbold R; Gantenbein C; Stallone F; Rentsch K; Rubini Gimenez M; Kozhuharov N; Sabti Z; Breitenbücher D; Wildi K; Puelacher C; Honegger U; Wagener M; Schumacher C; Hillinger P; Osswald S; Mueller C
    Eur J Heart Fail; 2017 Feb; 19(2):226-236. PubMed ID: 27758007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
    Biegus J; Hillege HL; Postmus D; Valente MA; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Massie BM; Metra M; Teerlink JR; Voors AA; O'Connor CM; Ponikowski P
    Eur J Heart Fail; 2016 Jul; 18(7):830-9. PubMed ID: 27170455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure.
    Ter Maaten JM; Damman K; Hanberg JS; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Cotter G; Davison B; Cleland JG; Bloomfield DM; Hillege HL; van Veldhuisen DJ; Voors AA; Testani JM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score.
    AbouEzzeddine OF; Wong YW; Mentz RJ; Raza SS; Nativi-Nicolau J; Kociol RD; McNulty SE; Anstrom KJ; Hernandez AF; Redfield MM;
    J Card Fail; 2016 Nov; 22(11):853-858. PubMed ID: 26718344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.
    Patel RB; Vaduganathan M; Rikhi A; Chakraborty H; Greene SJ; Hernandez AF; Felker GM; Redfield MM; Butler J; Shah SJ
    JACC Heart Fail; 2019 Jan; 7(1):47-55. PubMed ID: 30409707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).
    Wan SH; Stevens SR; Borlaug BA; Anstrom KJ; Deswal A; Felker GM; Givertz MM; Bart BA; Tang WH; Redfield MM; Chen HH
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27512103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies.
    Davison BA; Metra M; Cotter G; Massie BM; Cleland JGF; Dittrich HC; Edwards C; Filippatos G; Givertz MM; Greenberg B; Ponikowski P; Voors AA; O'Connor CM; Teerlink JR;
    JACC Heart Fail; 2015 May; 3(5):395-403. PubMed ID: 25951761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.